Showing results (91-100 of 226) with videos related to

Sort By:
Pageof 23
Cell Host & Microbe|July 11, 2014
Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatasesAnnelies W Mesman, Esther M Zijlstra-Willems, Tanja M Kaptein, et al.
EJNMMI Research|June 2, 2016
(18)F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myelomaJ C Regelink, P G Raijmakers, N Bravenboer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2022
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factorGerben J C Zwezerijnen, Jakoba J Eertink, Maria C Ferrández, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2015
Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1Linda M van den Berg, Sylvain Cardinaud, Angelic M G van der Aar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2018
Interobserver Agreement of Interim and End-of-Treatment 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and TrialsCoreline N Burggraaff, Alexander C Cornelisse, Otto S Hoekstra, et al.
EJNMMI Physics|February 8, 2026
Segmentation method comparison for baseline [18F]FDG PET-CT in follicular lymphoma patientsAnouk D M Nijman, Sanne E Wiegers, Gerben J C Zwezerijnen, et al.
The Lancet. Haematology|March 26, 2021
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)Sarah Gillessen, Annette Plütschow, Michael Fuchs, et al.
Journal of Cancer Survivorship : Research and Practice|April 22, 2024
Cardiovascular screening outcomes in the Dutch survivorship care program for Hodgkin lymphoma survivorsEline M J Lammers, Annelies Nijdam, Josée M Zijlstra, et al.
Frontiers in Pharmacology|June 3, 2016
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?Yvonne W S Jauw, C Willemien Menke-van der Houven van Oordt, Otto S Hoekstra, et al.
Frontiers in Medicine|December 25, 2023
Case report: XMEN disease: a patient with recurrent Hodgkin lymphoma and immune thrombocytopeniaPieter F de Groot, Arjan J Kwakernaak, Ester M M van Leeuwen, et al.
Pageof 23